Declaration of Conflict of interest: Grace LH Wong has served as a speaker for Echosens.
How does hepatitis B virus infection react to hepatocellular carcinoma treatment?
Article first published online: 21 DEC 2011
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd
Journal of Gastroenterology and Hepatology
Volume 27, Issue 1, pages 1–2, January 2012
How to Cite
Wong, G. L.-H. (2012), How does hepatitis B virus infection react to hepatocellular carcinoma treatment?. Journal of Gastroenterology and Hepatology, 27: 1–2. doi: 10.1111/j.1440-1746.2011.06950.x
Declaration of funding interests: None.
- Issue published online: 21 DEC 2011
- Article first published online: 21 DEC 2011
- Accepted for publication 18 September 2011.
- 5Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma: report of a prospective study. Am. J. Gastroenterol. 2005; 100: 2194–200., , et al.Direct Link:
- 6Effect of transcatheter arterial chemoembolization on HBV DNA level in primary liver cancer patients. Chin. J.Cancer 2009; 28: 1–5., , et al.
- 11Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma. Aliment. Pharmacol. Ther. 2011; 33: 1104–12., , et al.
- 13Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection. Am. J. Gastroenterol. 2008; 103: 1663–73., , et al.Direct Link:
- 19Antiviral therapy using lamivudine and thymosin alpha1 for hepatocellular carcinoma coexisting with chronic hepatitis B infection. Hepatogastroenterology 2006; 53: 249–52., , et al.